All Industries

Amesite Inc. In 2024: Growth, Partnership Building And Scaling A Zero Setup Cost AI-Driven Platform

Benzinga

By Faith Ashmore, Benzinga AI is rapidly gaining momentum and transforming industries across the board, even those that have traditionally been slow to adopt new technologies, like academia. As states increasingly recognize the need to build highly skilled workforces, community and regional colleges and universities in the U.S. are playing a more vital role than ever before. To accomplish their missions, these institutions often require more advanced software and services that can facilitate large-scale workforce development quickly and efficiently. AI-powered solutions are proving to be increasingly useful in achieving operational efficiency and meeting the needs of the future. However, not every university and college has the resources or knowledge to fully invest in AI technology. Amesite Inc. (NASDAQ: AMST) is an artificial intelligence software company that offers a cloud-based learning platform for businesses and education. The company's smart and intuitive learning environments assist organizations – including businesses, community colleges, universities, non-profits and government agencies – to launch branded learning programs easily and affordably. With a focus on providing innovative solutions, Amesite enables organizations to evolve with the times by offering a zero-cost set-up fee platform that leverages AI and facilitates personalized, engaging and efficient learning experiences. The company is known for its best-in-class learning management system (LMS) which can integrate with thousands of Application Programming Interface (APIs), enabling them to share information with different software applications. The past year saw the strategic evolution of Amesite’s business strategy to better serve its partners by moving to a much more affordable business plan with a no-cost set-up fee model, which is a key differentiator from other SaaS e-learning platforms. This change was made economically possible by the company’s implementation of its AI capabilities. The no-cost set-up fee approach significantly expands the target market for Amesite and enables companies and universities to provide professional training without big upfront investments and offer degrees and certifications to students with lower tuition fees than the competition. From an internal standpoint, Amesite says prioritizing AI-first processes and workflows has had an impact of reducing operating expenses by 51.9%. The company also reports that sales-qualified leads have seen a nearly 200% increase from the first quarter of 2023 to the first quarter of 2024. Before AI took off and was widely adopted, Amesite reports it was already engaging with and adopting the technology as one of the first ed-tech companies to embrace AI. Amesite reports it has gained momentum when compared to competitors and is now able to provide a cost-efficient product to its customers through a no-cost set-up fee model – effectively making it risk-free. Although from another industry, this is a similar approach to how Tesla (NASDAQ: TSLA) approached its EV business model and took a mass-market approach. Tesla created a standard in the auto industry that enabled it to bring on more customers, and Amesite similarly aims to set a standard in its educational industry utilizing AI in the background. Over the course of 2023, Amesite made strides in both the private and public sectors, which cumulated into the no-cost set-up fee model which has increased sales inquiries. In March, Amesite announced that it was COPPA and FERPA -compliant; these designations protect children’s safety and personal data online. This certification allows Amesite’s customers to sell learning products to over 49.5 million K12 students. The company reports that it has already seen success with the continued education market. In June, the company announced that company had received an award from the National Association for Business Resources: Michigan’s Best & Brightest in Wellness® for the fifth consecutive year. The company also announced 12 new courses with its partner, Michigan Works! Southeast (MWSE) during the year. These courses focused on how digitalization is reshaping the workplace, providing Michigan residents with valuable resources to excel in the modern workplace. In August, Amesite announced the renewal of its partnership with Central Michigan University. While there are other companies in the ed-tech space like Coursera (NYSE: COUR) and 2U (NASDAQ: TWOU), Amesite’s early AI adoption and continued evolution are beginning to result in more potential sales activity for the company in addition to achieving its no-cost set-up fee milestone but (significantly for investors) this shift began to roll out in September 2023, with an understandable delay in contract announcement wins. The company now boasts of being able to provide custom-branded, enterprise-scale systems for clients within 24 hours – and partners seem to be taking notice. Since the official rollout in September, the company announced a five-year partnership with Drake State Community and Technical College in November. Amesite also announced a five-year partnership with West Virginia Northern Community College in December. Amesite’s commitment to providing companies and organizations with the tools needed to leverage powerful AI at a low cost and with scalable options sets it apart from its contemporaries and its competition. Speaking on the commercial demand for Amesite’s tools, CEO and Founder Dr. Ann Marie Sastry shared, “Workforce development agencies have a significant opportunity to leverage modern tools to assist individuals in their growth and readiness for the job market, and we are excited to be able to provide critical skills to a multi-billion-dollar market and expect these offerings to be in high demand. At Amesite, we've focused on creating solutions that easily integrate into existing systems. Our partnership with Microsoft enables us to deploy these tools swiftly, often within a 24-hour window.” According to Market Research Future, the global AI in education market is projected to grow from $3.45 billion in 2023 to $23.82 billion in 2030. The SaaS market is expected to grow from $167 billion in 2022 to $462 billion by 2028. As Amesite’s progress indicates, companies that capitalize on these two industries and drive growth forward could have a positive outlook in the coming years. As Amesite begins to see the positive results of its new AI-enable model, investors may see that Amesite could potentially be well-positioned to continue to grow and expand its partnerships, resulting in more clients and more revenues. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

February 01, 2024 09:10 AM Eastern Standard Time

Mariner Wealth Advisors Acquires AndCo Consulting and Fourth Street Performance Partners, Creating Mariner Institutional

Mariner

Mariner Wealth Advisors, a national wealth advisory firm, today announced it will be acquiring Winter Park, Fla.-based AndCo Consulting and Covington, Ky.-based Fourth Street Performance Partners in a simultaneous transaction. The acquisitions significantly bolster Mariner’s institutional presence, adding 100 associates and bringing the firm an additional $104 billion in assets under advisement. Based on its approximately 25 years of operational experience, the AndCo team will drive the new business vertical, Mariner Institutional. Recognizing the evolving landscape of retirement-to-wealth solutions, Mariner’s strategic addition of these two firms supports the firm in offering a comprehensive suite of complementary services, catering to both institutional and individual clients. The expansion enhances Mariner’s capabilities and growth potential, solidifying its commitment to a client-first approach. “The complementary nature of our clients and services will support our joint growth and offer existing clients and prospects additional services that will help enhance the overall client outcome,” said Marty Bicknell, CEO and president of Mariner Wealth Advisors. “Mariner, AndCo and Fourth Street share an objective and client-first approach, a focus on associate development and unyielding support for our communities. This leads to a strong cultural alignment and great opportunities ahead.” Fourth Street will merge with AndCo upon closing of the transaction, each maintaining their existing teams and focus on serving institutional clients under the Mariner Institutional brand. Joining Mariner allows them to augment services through enhanced infrastructure and financial resources. “Since the inception of the firm, we have consistently approached business decisions through a simple three-pronged question: how will this impact our clients, our colleagues and our community?” said AndCo CEO Mike Welker. “We truly believe we have found a partner in Mariner that shares the same philosophy, and I’m confident this opportunity will enhance the services we deliver to our existing clients, provide opportunities for our team members and give us capacity to give back to our local communities at scale.” The agreements were finalized on Jan. 29, 2024, and the transition is expected to reach its completion in early April 2024. Berkshire Global Advisors served as financial advisor to AndCo Consulting in this transaction. AndCo and Fourth Street will retain their 100 professionals and continue serving clients out of their locations in Covington, Winter Park, Chicago, Dallas, Detroit, Pittsburgh, Cleveland and Reno, Nev. At Mariner Wealth Advisors, we provide 360° advice designed to last. We focus on one thing—partnering with clients to create a financial strategy for today and beyond that’s flexible enough to change along with them. The ultimate goal? Helping clients identify what is important so they can achieve their goals—we’re committed to being here for everything life brings their way. We’ve built our firm around what our clients need. We began by offering wealth planning resources and then added services from tax planning to insurance—all under one roof. We believe this integrated approach to wealth management helps simplify our clients’ lives. Founded in 2006 with $300 million in assets under advisement, Mariner and its affiliates now advise on over $122 billion in assets as of 12/31/23. To learn more, visit marinerwealthadvisors.com. Contact Details Remi Yuter mariner@hotpaperlantern.com Company Website https://www.marinerwealthadvisors.com/

February 01, 2024 09:00 AM Eastern Standard Time

Image

World’s largest radiology AI marketplace CARPL raises $6m to accelerate the adoption of AI in clinical workflows

CARPL

As people live longer and as emphasis on early detection of disease increases, there is a mounting burden on the healthcare services industry globally. This is being especially felt in radiology teams who are witnessing an acute shortage of radiologists. Currently, there are over 200 companies building applications using AI to automate parts of the radiologists’ work to bridge this talent gap. Today CARPL, an enterprise imaging AI marketplace platform, is announcing a $6m funding round to enable healthcare providers to access, assess and integrate these radiology AI applications into their clinical workflows through a single user-interface, single data channel and single procurement system. The seed funding round was led by Stellaris Venture Partners, a leading enterprise software investor, with participation from strategic angel investors* from Novo Holdings, Leapfrog PE, Bain & Co, Boston Consulting Group, UnitedHealth Group among others. CARPL will use the fresh funds to expand the team in North America and continue to build its tech stack. With more than 700 US-FDA approved AI applications, healthcare providers grapple with navigating the complex landscape of niche AI solutions. The daunting task involves determining the best AI solution for them and their patients, then seamlessly integrating it in the radiologists' workflows. This complexity has resulted in the sluggish pace of AI adoption in healthcare. A recent joint statement by the world’s top radiology associations also brings to light the importance of validation, deployment and monitoring of AI while being used in clinical practice. CARPL’s technology platform addresses this need using its proprietary DEV-D framework allowing healthcare providers to first Discover (D), Explore (E) and Validate (V) AI applications from CARPL’s AI marketplace, and subsequently Deploy (D) the most appropriate application across their clinical workflows. CARPL stands out as the only platform in the market with deep AI validation and monitoring capabilities, thereby ensuring safe and seamless AI deployment while upholding patient-centricity at its core. Additionally, CARPL’s universal AI viewer serves as a single user interface for radiologists, enabling them to accept, reject or refine AI outputs, which can subsequently be used to improve the performance of the AI itself. Operational since 2021, CARPL was founded by Vidur Mahajan, a physician with an MBA from the Wharton School of Business who has spent more than 12 years in the diagnostics industry. CARPL’s leadership comprises Dr Vasanth Venugopal as Chief Medical Officer, Rohit Takhar as CTO and most recently Dhruv Sahai as COO. CARPL has also ramped up its advisory team with the appointment of Dr Vijay Rao, SVP of Enterprise Imaging at Jefferson Health and a past-President of the Radiology Society of North America. “Over the past two years, we have onboarded more than 50 AI developers having 100+ AI applications, which made us the largest AI marketplace in terms of number of AI applications offered to customers. We are proud that some of the largest healthcare enterprises in the world have vetted our technology and trust us to be their partner in their AI and automation journeys.” said Dr Vidur Mahajan, CEO of CARPL. Drawing parallels with the lab medicine industry, Vidur Mahajan added: “We are democratizing radiology in the same way that automation and robotics revolutionized lab medicine, where a single pathologist signs out thousands of tests each day. We envision a future where CARPL creates ‘super-radiologists’ - AI-enabled radiologists who are ten times more productive than traditional radiologists.” Vidur Mahajan brings deep domain expertise having previously grown revenue 10x to $20m in 10 years at his family business Mahajan Imaging, a leading radiology service provider. He conceptualized CARPL under the guidance of his father Dr Harsh Mahajan, a pioneer in radiology, while working on validation and deployment of AI at Mahajan Imaging. CARPL comprises a multidisciplinary team with clinicians, scientists, engineers and business experts, all working towards the singular goal of driving exponential health outcomes using the encapsulated value of the entire AI ecosystem with the ultimate aim of ensuring access of quality diagnostics to patients. CARPL has more than 120 papers and conference presentations to its credit, and has coined some seminal concepts in clinical AI such as algorithmic audits, clinical explainability failure and unboxing AI. CARPL’s technology platform is used by the world’s top healthcare organizations like the Singapore Government, Massachusetts General Hospital (Boston), Radiology Partners (Los Angeles), University Hospitals (Cleveland), I-MED Radiology (Australia), Albert Einstein Hospital (São Paulo), Clinton Health Access Initiative, to name a few. CARPL is also creating impact in the public health space by working with the Government of India to enable large scale Tuberculosis Screening Programmes in the most remote regions of the country. As the global disease burden increases, owing to aging populations, early detection of disease and an increase in chronic/lifestyle diseases, the need for radiology services will increase, which increases the need for AI-assistance and automation in the delivery of these services. The global healthcare AI market is expected to cross $170 billion by 2029, of which almost $20 billion will be in the domain of radiology. Today, of the about 700 AI-based applications which are approved by the US-FDA, 80% are related to radiology. This number is expected to grow exponentially as access to training data and computation power becomes cheaper and easier to access. Alok Goyal, Partner at Stellaris Venture Partners commented: “The volume of imaging scans show a steady 9% year-on-year growth, outpacing the growth in the number of radiologists at a mere 1.8%. Bridging this demand gap is a crucial challenge for healthcare providers, and we believe AI will be the key. CARPL's integrated platform, designed for testing, deploying, and monitoring radiology AI applications, is poised to empower healthcare providers by seamlessly integrating AI into their clinical workflows. We are thrilled to join forces with Vidur and his team on this transformative journey.” As it becomes easier to build AI, the number and nature of AI applications used by doctors to deliver healthcare will increase exponentially. A platform approach that builds on connecting these AI developers to healthcare providers is the only way to exponentially improve the access, affordability and quality of care delivered today. CARPL is a new layer in the healthcare CIO’s stack that enables seamless access to the entire AI and analytics ecosystem through a single integrated platform. About CARPL CARPL is democratizing access to high quality healthcare by connecting AI applications and healthcare providers, exponentially improving the access, affordability and quality of medical care. CARPL enterprise imaging AI platform provides a single user-interface, data channel and procurement system for healthcare providers to access, assess, integrate and buy radiology AI applications in a safe and seamless manner. CARPL was incubated at Mahajan Imaging & Labs, India’s largest radiology service provider, as its technology division focused on building scalable clinical tools for AI validation, deployment and monitoring, under the guidance of Dr Harsh Mahajan, a pioneer in the field of radiology. For more information please visit https://carpl.ai About Stellaris Venture Partners Stellaris is an early-stage tech-focused VC firm that partners with fearless founders who dream big, think differently, and have an unstoppable desire to challenge the status quo. The fund works with these teams at nascent stages to help transform their ideas into resilient businesses. Stellaris does so with a team of seasoned, diverse operators and entrepreneurs who bring significant experience in building businesses and by providing access to some of the most successful founders and professionals. Since its inception in 2017, Stellaris has backed many market leaders such as Mamaearth, Whatfix, Propelld, Turno, Rigi, and others. For more information on Stellaris Venture Partners, visit https://www.stellarisvp.com Contact Details CARPL Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com Company Website https://carpl.ai/

February 01, 2024 09:00 AM Eastern Standard Time

Image

VTS Selected Among GlobeSt.’s 2024 Influencers in Commercial Real Estate Technology

VTS

NEW YORK – February 1, 2024 – VTS, the industry's only technology platform that unifies owners, operators, brokers, and their customers across the real estate ecosystem, today announced that GlobeSt. has recognized Chief Executive Officer: Nick Romito, and Chief Strategy Officer: Ryan Masiello as honorees on its 2024 Influencers in Commercial Real Estate Technology list. This is the company’s fourth year being featured on the list, having also won in 2020, 2022 and 2023. “We at VTS are immensely proud to be recognized as one of GlobeSt.’s Influencers in Commercial Real Estate Technology for a fourth year, a testament to our team’s unwavering commitment to pioneering innovation for commercial real estate,” said Romito. “2023 was an incredible chapter for our company, and we look forward to continuing to provide the industry with the most comprehensive tech solutions on the market.” Romito and Masiello were recognized for their leadership throughout 2023 and beyond, having most recently spearheaded the launch of VTS’ tenant experience platform VTS Activate in May. Leveraging the previous acquisitions of Rise Buildings and Lane Technologies in 2021, VTS Activate is a revolutionary tenant experience platform that enables commercial real estate owners and operators to create a fully integrated, campus experience and provide first-of-its-kind ‘one app, access anywhere’ functionality for tenants and employees. VTS Activate comes on the heels of the company’s CBRE-led $125M Series E fundraise in September 2022, which marked another major milestone for the co-founders who started the company back in 2012. “Having founded VTS over a decade ago, it is incredible to see just how much our company has evolved and continues to be acknowledged as a leader in the PropTech sector,” said Masiello. “We’re thrilled to kick off 2024 with this recognition and to reaffirm our team’s dedication to advancing the industry with meaningful solutions.” For this year’s Influencer series, GlobeSt. Real Estate Forum aimed to highlight the accomplished and impactful individuals and leadership teams that are creating revolutionary solutions solving for today’s industry challenges and market woes. The professionals featured on this list have impacted the marketplace through new and/or improved technology applications, their first-of-its-kind contributions to the industry, the vast successes they boast, and/or the innovations and best practices they’ve introduced to the business. About VTS VTS is the industry's only technology platform that unifies owners, operators, brokers, and their customers across the commercial and residential real estate ecosystems. In 2013, VTS revolutionized the commercial real estate industry’s leasing operations with what is now VTS Lease. Today, the VTS Platform is the largest first-party insights and collaboration engine in the industry, transforming how strategic decisions are made and executed by real estate professionals across the globe. With the VTS Platform, consisting of VTS Lease, VTS Market, VTS Activate, and VTS Data, every stakeholder in real estate is given real-time market information and workflow tools to do their job with unparalleled speed and intelligence. VTS is the global leader, with more than 60% of Class A office space in the U.S., and 13 billion square feet of office, residential, retail, and industrial space is managed through our platform worldwide. VTS is utilized by over 45,000 professionals and over 1.2 million total users, including industry-leading customers such as Blackstone, Brookfield Properties, LaSalle Investment Management, Hines, BXP, Oxford Properties, JLL, and CBRE. To learn more about VTS, and to see our open roles, visit www.vts.com. Contact Details Eric Johnson eric.johnson@vts.com Company Website https://www.vts.com/

February 01, 2024 09:00 AM Eastern Standard Time

Leading Chronic Disease and Brain Health Clinic Unveils Second Location in Northern Virginia, Washington, D.C. Metro

Forum Health

Forum Health, LLC, national integrative and functional medicine network, is trailblazing the fight against cognitive decline, chronic disease, and aging with a new, state-of-the-art clinic in Lansdowne, Virginia. Led by renowned multi-certified practitioner Lynese L. Lawson, D.O., Board-Certified in Anti-Aging/Regenerative Medicine (ABAARM), Bredesen ReCode 2.0, and the Institute for Functional (IFM), Proactive Wellness Centers offers advanced therapies for hormone imbalance, cognitive decline, weight loss, Lyme disease, sexual health and health optimization services for patients who want to “bio hack” their health. Learn about the new Proactive Wellness Centers by Forum Health clinic here. The clinic previously joined Forum Health mid-year in 2023 with a location in Tysons Corner, Virginia, and merges the latest scientifically validated integrative medicine treatments with conventional therapies. Dr. Lawson has deep expertise in the prevention and reversal of cognitive decline, as one of the elite Bredesen Protocol practitioners under the new ReCode 2.0 protocol, and provides the most comprehensive brain health assessment and treatment in the Mid-Atlantic region. Dr. Lawson, Founder and Medical Director, Proactive Wellness Centers by Forum Health: “We’re thrilled to expand to a second location under the Forum Health brand and look forward to helping even more patients optimize their health, overcome chronic diseases, stop and reverse cognitive decline and achieve vibrant health.” Proactive Wellness Centers in Lansdowne opened its doors on December 18, 2023 with a successful open house offering guests a glimpse of the new facility with complimentary body composition testing and clinic tours. Today marks the start of seeing patients at the new location. The practice has been serving Northern Virginia, Washington D.C., Maryland, Pennsylvania and out-of-state patients since 2006 with precision medicine including: Bioidentical Hormone Replacement Therapy Bredesen Protocol for Alzheimer's Disease Medical Weight Loss Sexual Health Chronic Disease Treatment for Lyme, Mold, Epstein-Barr virus Thyroid Disease Adam Puttkammer, Forum Health President: “With a growing aging population, chronic disease and cognitive decline are two of the greatest health factors many patients are facing. We are also seeing a surge in patients that are healthy but want to optimize their wellness. Forum Health is well positioned to service this population of biohackers and patients that want to prioritize their health. While more people are living longer, it’s not just about years – but the quality of those years. I’m confident Dr. Lawson’s expanded reach will be of great value to our patients.” About Forum Health, LLC Forum Health, LLC is a nationwide provider of personalized healthcare steeped in the powerful principles of functional and integrative medicine. Our providers take a root-cause approach to care exploring lifestyle, environment, and genetics to help each patient achieve their ultimate health goals. Members have access to advanced medical treatments and technology, with care plans informed by data analytics and collaborative relationships. Visit www.forumhealth.com. Contact Details Forum Health, LLC Britt Wittelsberger +1 410-852-0738 bwittelsberger@forumhealth.com Company Website https://forumhealth.com

February 01, 2024 08:50 AM Eastern Standard Time

The Best AI Girl Generator Apps You Must Try 2024

Summit Ventures BV

In today's technologically driven world, AI girl generator apps have gained immense popularity for their ability to create virtual AI companions. With a plethora of options available, we've curated a list of top-notch AI girl generator tools that you should explore in 2024. These applications offer innovative AI girl generation capabilities, providing unique and engaging experiences. Table of Featured AI Girl Generators 1. Introduction to AI Generated Girls 2. Featured AI Girl Generator Tools 2.1 GPTGirlfriend.online 2.2 GlamGirls.ai 2.3 ChaiApp.pro 2.4 AI-Girlfriend.co 2.5 AI-Companion.co 3. Frequently Asked Questions 4. Conclusion Top Five AI Girl Generator Apps The world of AI girl generators has seen significant growth, offering a variety of engaging options. While each application brings its unique features to the table, GPTGirlfriend.online stands out with its exceptionally engaging interactions and a wide range of capabilities. Girlfriend GPT: Your Gateway to AI Generated Girls Girlfriend GPT is an innovative AI-powered tool that brings your favorite AI girl characters to life, offering interactive experiences. This platform provides a wide array of activities, enabling you to create a virtual space for engaging conversations with your AI girl companion. Moreover, GPTGirlfriend.online offers unrestricted content for a diverse experience. Key Features: Empowers you to create your personalized AI girl companion. Allows unrestricted interactions and conversations. Offers affordable premium and deluxe subscription plans. Resumes conversations with long-term memory. Glam Girls AI: Generate your AI Girl in Seconds Glam Girls is renowned for having the best AI generated girls in the space. This platform is designed for those interested in crafting glamorous AI characters. Whether you're looking for AI girls with a sense of style or unique personalities, GlamGirls.ai has you covered. Key Features: Multiple scenarios for AI girl generation. Customizable interface to align with your preferences. Accommodates various interests and preferences in AI girl characters. Chai App: Create AI Girls for NSFW AI Images Chai App offers an intuitive platform for generating AI girls and companions, particularly suited for NSFW AI image generation. This application excels in providing realistic AI chatbot interactions and customization options for your AI girl companions. Key Features: Intuitive navigation for an immersive experience. Realistic chatbot interactions. Allows customization of AI girl companions. Features advanced capabilities for generating AI girls. AI Girlfriend: Personalized AI Girlfriends for Engaging Conversations AI-Girlfriend.co is the perfect choice for those seeking personalized AI girlfriends. This platform allows you to tailor your AI girlfriend according to your preferences. AI-Girlfriend.co creates engaging and realistic interactions with your ideal AI girlfriend character. Key Features: Provides realistic AI companion interactions with varied emotions and backgrounds. Abundance of features available for diverse AI girlfriend interactions. Offers budget-friendly pricing for personalized AI girlfriends. AI Companion: Engage with AI waifus and husbands AI-Companion.co is known for its wide range of character options in the AI girl generator domain. This versatile platform accommodates various conversations and interactions with AI chatbots, offering personalized experiences. Key Features: Support for multiple languages, enhancing accessibility. Personalization options to tailor the chatbot according to individual preferences. Broad spectrum of interests and character types for diverse user needs. Frequently Asked Questions Q: What is an AI girl generator? A: An AI girl generator is a software application that uses artificial intelligence to create virtual AI girl characters for various purposes, such as entertainment, interaction, or chatbot companionship. Q: How do AI girl generators work? A: AI girl generators work by utilizing advanced algorithms and machine learning techniques to generate AI girl characters with customizable traits, personalities, and conversation capabilities. Q: Can a AI girl generator be used for NSFW content? A: Some AI generated girls are designed to cater to NSFW (Not Safe For Work) content, offering options for more mature and adult-themed interactions. However, not all AI girl generator apps support explicit content. Q: Can I customize AI girl characters generated by these tools? A: Yes, most AI girl generator apps allow users to customize AI girl characters by selecting specific traits, appearances, and personalities to create personalized virtual companions. Q: Are there age restrictions for using AI girl generators? A: Yes, to use AI girl generators, users typically need to be at least 18 years old, as these tools may generate content that is intended for adults. Conclusion In the realm of technology, AI generated girls offer a gateway to interactive virtual companionship. These tools have transformed how we connect with AI characters, providing endless entertainment and personal interactions. Whether you seek customizable AI girls, engaging AI girlfriends, or glamorous AI characters, these apps cater to diverse preferences. They bridge the virtual and real worlds, offering a glimpse into the potential of AI companions. This guide has highlighted top AI girl generator apps in 2024, each with unique features. Some may include NSFW content, so choose accordingly. AI girlfriend apps pioneer technological innovation, enabling users to create, personalize, and interact with AI characters. Explore these apps for a distinctive experience in the world of AI companionship. Unlock the potential of AI girl generators today. GPTGirlfriend.online is the most advanced AI companion subscription service with a community of more than 1,000,000 Monthly Active Users. With more than 25,000 characters, it has transformed how people interact with and experience AI. Please refer to our detailed Terms of Use and Community Guidelines for comprehensive information on usage, safety, and ethical considerations on GPTGirlfriend.online Contact Details GPTGirlfriend Business hello@enias.io Company Website https://www.gptgirlfriend.online

February 01, 2024 08:30 AM Eastern Standard Time

Image

Decoding Canada’s Critical Minerals Strategy: Insights From The Canadian Critical Minerals Opportunities Forum With Attendees Like Arianne Phosphate (OTCMKTS: DRRSF) President Brian Ostroff

Arianne Phosphate

By Meg Flippin, Benzinga From shoring up the food supply to creating a greener future, Canada is pouring billions of dollars into increasing the supply of critical minerals to necessitate those goals and expand its economy. Under the Canadian government’s Critical Minerals Strategy, which it launched in 2022, $4 billion is being budgeted to increase the supply of responsibly sourced critical minerals needed for everything from electric vehicles to energy storage to food. At the same time, the country is courting investors and businesses that may want to tap its mineral-rich resources. EVs A Big Market Take the electric vehicle market for one example. Canada is the only country in the Western Hemisphere that has all the minerals needed to produce batteries for electric vehicles. That puts it in an enviable position given the world is moving rapidly toward EVs. The global EV market is projected to reach $693 billion by 2030, growing at a CAGR of 17.3% from now until then. Canada is also rich in phosphate and potash, two macronutrients that play roles in the growth, health and output of crops. Some leaders within the Canadian government want those two minerals added to the critical minerals list. Outside of Canada, much of the phosphate rock is found in the Middle East and North Africa or MENA region, which is facing political unrest and economic instability. That makes getting it from outside sources costly and unreliable. It is also another selling feature Canada is trying to capitalize on. Selling Canada Critical Mineral Producers All of those insights were on display at a recent Canadian Critical Minerals Opportunities Forum, which brought together the miners and producers of these critical minerals and investors, lawmakers and businesses working toward a greener tomorrow, including Arianne Phosphate Inc. (OTCMKTS: DRRSF). The mining company out of Quebec, Canada operates the Lac à Paul project in Quebec, the world’s largest greenfield phosphate rock project. It consists of several mineralized zones that will produce high-quality phosphate rock with little or no contaminants. Arianne’s deposit is igneous and thus, geologically rare. The company reports that this allows it to produce a much purer phosphate concentrate compared to those that produce phosphate from sedimentary deposits. It is worth noting that igneous deposits produce under 10% of all phosphate, making them highly prized. Arianne’s mine, which it reports adhere to strict environmental, social and corporate standards, also contain few or no contaminants. It also helps that the mine is located in a mining and investment-friendly jurisdiction with a well-developed infrastructure that includes clean energy, heavy haul roads, easy access to ports and skilled labor. The company hopes to become a major supplier to the West and to counterbalance the dominance of China. Supply Is Dwindling Arianne Phosphate reports that its Lac à Paul project is also the only independent large-scale development project coming on stream in the next few years and should become a big supplier as a result. It’s not just for fertilizer – there are several markets Arianne’s mine can serve including consumer products, food preservatives, animal feeds, cosmetics, detergents, industrial processes, semiconductors and LFPs. “At the Conference, I was able to attend some interesting panels, gaining insight from other industry leaders. I was also able to present Arianne Phosphate and its best of class Lac à Paul phosphate deposit in Quebec, Canada,” says Brian Ostroff, President of Arianne Phosphate about the investment forum. “It is exciting to see the growing understanding and interest in phosphate as a critical mineral required for next-generation batteries and energy transition. Arianne is well-positioned to serve this growing market in the years to come.” ARIANNE PHOSPHATE INC. ( www.arianne-inc.com ) owns the Lac Ã Paul phosphate deposit in Quebec, Canada. Fully permitted and shovel ready, the asset is among the worldâs largest greenfield deposits, capable of producing an environmentally friendly phosphate concentrate. Due to the nature of its high-purity, low-contaminant product, Arianneâs phosphate can be used to produce fertilizer as well as meeting the technical requirements of specialty applications such as the lithium-iron-phosphate (LFP) battery. The Lac Ã Paul deposit is rare due to its geographic location and geological structure. Arianne Phosphate is listed on both the TSX-V: DAN and the OTCQX: DRRSF. This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. This information contains forward looking statements. All statements, other than statements of historical fact, included herein, including without limitation, statements regarding potential mineralisation and reserves, exploration results and future plans and objectives of Arianne Phosphate Inc, are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Arianne Phosphate Inc (Arianne Phosphate or the Company) expectations are disclosed under the heading "Risk Factors" and elsewhere in Arianne Phosphate Inc documents filed from time-to-time with the TSX Venture and other regulatory authorities. Contact Details Brian Ostroff, President brian.ostroff@arianne-inc.com Company Website https://www.arianne-inc.com

February 01, 2024 08:30 AM Eastern Standard Time

With An Anticipated Supply Gap, Has The Recent Sell-Off In Lithium Equities Created Opportunities For Investors?

Lithium Ionic

By Jeremy Golden, Benzinga When demand exceeds supply, new opportunities arise. Such seems to be the case for Lithium Ionic Corp. (TSXV: LTH; OTCMKTS: LTHCF), a company that is quickly advancing its lithium projects in Brazil, with first production expected within the next 24 months. Lithium is among the most important metals required for electric vehicles and energy storage. With demand for metal ramping up, analysts are forecasting a lithium shortage as soon as 2025. That means demand for lithium could increase exponentially in the coming years, with research firm Wood Mackenzie predicting a widening supply-demand gap in the coming years. Companies involved could stand to benefit, especially those with near-term production profiles. With the goal of generating long-term value for its shareholders through the discovery and future extraction of high-quality lithium and keeping in mind the anticipated supply gap, Lithium Ionic may present an opportunity for investors interested in ownership of a company that could potentially become a major player in the global lithium supply chain to support the transition to a green economy. The recent sell-off in lithium equities has presented an opportunity for interested investors to build positions in high-quality emerging companies such as this one. Coming Soon: Bandeira Lithium Project There are currently just 101 lithium mines in the world. While hundreds more are currently under exploration, few are prepared to handle the geological complexities and time-sucking permitting processes involved. In contrast, Lithium Ionic stands out in this regard. Lithium Ionic is developing lithium properties in Brazil with the goal of extracting lithium in the near future. Located in the mining-friendly Minas Gerais state in Brazil – right next door to Sigma Lithium’s already producing Grota de Cirilo Project and in the heart of Brazil’s “Lithium Valley” – Lithium Ionic’s properties span 14,182 hectares, or more than 35,044 acres, in this prolific lithium province in Brazil. Lithium Ionic’s extensive exploration work conducted in 2023, including over 85,000 meters drilled across four targets, significantly improved its understanding of the lithium-bearing pegmatites in the region and demonstrated both the large-scale and future discovery potential of lithium deposits in this district. Lithium Ionic is rapidly advancing Bandeira, its flagship project, toward a production decision with a Feasibility Study underway and construction permits expected mid-year, all the while continuing to explore other promising regional targets. Lithium Ionic's Bandeira project is high-quality and notable for several reasons. Jurisdiction is an important factor in the mining sector, and the Bandeira Project is in the same district where Companhia Brasileira de Litio’s Cachoeira mine has produced lithium for over 30 years. Thus, Lithium Ionic’s location in a mining-friendly locale is a huge boon for the company. Within a few kilometers from the Bandeira Project, Sigma Lithium operates the largest hard rock lithium deposit in the Americas – its Grota do Cirillo project. Developing a lithium operation next to a multi-billion dollar lithium producer could allow Lithium Ionic to mirror its successful development. The Bandeira project is expected to be a major cash generator. Based on an initial engineering study published last year the project showed an NPV of US$1.6 billion and a 121% internal rate of return, with a CAPEX of only $233 million, which can be paid back in just over 1 year. Lithium Ionic also shared that investors can expect results of a more detailed Feasibility Study this quarter. Lithium Ionic Following Blueprint Nextdoor? Sigma Lithium’s ~2,500% rise from Feasibility Study to First Production Bandeira is expected to achieve first production within the next 24 months, which the company reports is well ahead of any other upcoming major lithium project in the Americas. Lithium Ionic also reports that the project is following the exact template for development and production as its neighbor, Sigma Lithium, which, from Feasibility Stage to first production, experienced a share price increase of nearly 2,500%, rising from about $1.50 to $40 ( stock price from Feb 2020 and Oct 2022). As such, investors who liked their returns on Sigma Lithium or who may have missed this opportunity may want to keep an eye on Lithium Ionic. On its own, Bandeira seems to be a promising project, though it only represents 1% of Lithium Ionic's total land package. The company’s drilling activities continue to demonstrate consistency in the rocks, meaning Lithium Ionic could have several meaningful projects in Brazil's Lithium Valley in the near future. Major development milestones are on the horizon, as well. Lithium Ionic says it is preparing for some major announcements in the first half of this year, including the release of a definitive feasibility study – the final engineering study prior to construction of the project. Lithium Ionic is also preparing to release an initial resource estimate on the Salinas project – located approximately 100 km North of Bandeira, which it says will demonstrate the size and scale of its endeavors in this “Lithium Valley.” As demand for EV batteries and renewable technologies continues to grow, analysts are expecting lithium demand to rise. This, plus supportive government policies and growing consumer demand, could help bolster companies with strong footing in the lithium supply chain. With a large-scale project coming online soon, Lithium Ionic is one of a small set of companies that seem prepared to take advantage of this moment in the lithium industry. Lithium Ionic is a Canadian mining company focused on becoming the next significant Brazilian lithium producer. Our properties are located in Brazil’s Minas Gerais state, a mining-friendly jurisdiction that is quickly emerging as a world-class hard-rock lithium-producing district. A recent PEA for the Bandeira Project indicates a long-life, low-cost, and highly profitable project with a Post-tax NPV8% of US$1.6B (~C$2.2B) and IRR of 121%. Our goal is to generate significant returns for our stakeholders by becoming the country's next producer of high-quality spodumene concentrate for the global lithium supply chain. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Caroline Arsenault info@lithiumIonic.com Company Website https://www.lithiumionic.com/

February 01, 2024 08:20 AM Eastern Standard Time

First Patient Dosed In Phase 2 Study Of Elicio Therapeutics’ ELI-002 7P

Benzinga

By Jeremy Golden, Benzinga A phase 2 trial by a clinical-stage biotechnology company is kicking into full gear. As part of its randomized phase 2 AMPLIFY-7P study of ELI-002 7P as an adjuvant monotherapy in Kirsten Rat Sarcoma (KRAS) mutated pancreatic ductal adenocarcinoma (PDAC), Elicio Therapeutics Inc. (NYSE: ELTX) has dosed the first patient at Northwell Health Cancer Institute and the Feinstein Institutes for Medical Research in New York. ELI-002 7P is an investigational therapeutic cancer vaccine developed with Elicio’s proprietary lymph node-targeting Amphiphile (AMP) technology to treat cancers driven by seven common mutations in KRAS: G12D, G12R, G12V, G12A, G12C, G12S and G13D. Those are present in 25% of all solid tumor cancers and 88% of PDAC patients. This is in contrast to other KRAS-targeted therapeutics in development, particularly small molecule KRAS inhibitors. Those target fewer mutations – potentially limiting the number of patients who can be treated – while also limiting the duration of benefit due to the development of escape mutants. The AMPLIFY-7P study builds on preliminary positive findings from the 2-peptide formulation of ELI-002 published in Nature Medicine. That data demonstrated tumor biomarker reduction, with strong T cell responses that correlated with reduced risk of relapse and death. Christopher Haqq, M.D., Ph.D., Elicio’s Executive Vice President, Head of Research and Development and Chief Medical Officer, anticipates results from this study will yield definitive data to support clinical efficacy assessment. Initial interim data on ELI-002 7P monotherapy from phase 1A arm will be shared in the first half of 2024, the company said. “Approximately 90% of pancreatic cancers are positive for KRAS mutations, with only rare G12C mutations, about 1%, amenable to small molecule treatment,” Haqq said. “ELI-002 represents a cancer vaccine approach that could potentially address the much broader spectrum of pancreatic cancer KRAS mutations.” In January, Elicio presented a Trial in Progress poster on the design of the AMPLIFY-7P trial at the ASCO Gastrointestinal Cancers Symposium in San Francisco, California. The poster describes the phase 1 and randomized phase 2 study of ELI-002 7P, an investigational therapeutic cancer vaccine administered as an adjuvant monotherapy treatment for patients with KRAS-mutated pancreatic ductal adenocarcinoma (PDAC). “ELI-002 is an off-the-shelf cancer vaccine candidate developed with our proprietary Amphiphile (“AMP”) platform which provides a new ability to deliver these treatments effectively to the ‘command center’ of the immune response – the lymph nodes – where tumor-fighting T cells are generated and equipped,” Haqq said. “We are progressing our AMP-powered, lymph node-targeted cancer vaccine, ELI-002 7P, as a monotherapy in an adjuvant setting for patients with pancreatic cancer, and recently dosed the first patient in the randomized Phase 2 cohort.” “Patients with RAS mutated pancreatic cancers who have positive circulating tumor DNA post-surgery are often quick to relapse,” added Zev A. Wainberg, M.D., Professor of Medicine, University of California, Los Angeles (UCLA), Co-Director, the UCLA GI Oncology Program. “Our current standard of care for these patients is observation — there are no treatments given during this ‘wait and see’ observation window before relapse. As we progress to Phase 2 of the study, we seek to compare ELI-002 7P to our current standard of care to further evaluate its antitumor activity and clinical benefit in the adjuvant setting as well as with bulkier cancer treated at the time of relapse in crossover patients with mKRAS-driven pancreatic cancer.” Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

February 01, 2024 08:15 AM Eastern Standard Time

1 ... 445 446 447 448 449 ... 3758